- Home
- RDZN vs RFL Comparison
RDZN vs RFL Comparison
Compare RDZN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- RFL
- Stock Information
- Founded
- RDZN 2015
- RFL 2017
- Country
- RDZN United States
- RFL United States
- Employees
- RDZN N/A
- RFL N/A
- Industry
- RDZN Blank Checks
- RFL Real Estate
- Sector
- RDZN Finance
- RFL Finance
- Exchange
- RDZN Nasdaq
- RFL Nasdaq
- Market Cap
- RDZN 54.8M
- RFL 55.3M
- IPO Year
- RDZN N/A
- RFL N/A
- Fundamental
- Price
- RDZN $1.52
- RFL $1.84
- Analyst Decision
- RDZN Strong Buy
- RFL
- Analyst Count
- RDZN 2
- RFL 0
- Target Price
- RDZN $5.00
- RFL N/A
- AVG Volume (30 Days)
- RDZN 682.5K
- RFL 25.8K
- Earning Date
- RDZN 02-10-2025
- RFL 12-27-2024
- Dividend Yield
- RDZN N/A
- RFL N/A
- EPS Growth
- RDZN N/A
- RFL N/A
- EPS
- RDZN N/A
- RFL N/A
- Revenue
- RDZN $46,448,411.00
- RFL $697,000.00
- Revenue This Year
- RDZN $4.38
- RFL N/A
- Revenue Next Year
- RDZN $61.53
- RFL N/A
- P/E Ratio
- RDZN N/A
- RFL N/A
- Revenue Growth
- RDZN 57.97
- RFL 151.62
- 52 Week Low
- RDZN $0.71
- RFL $1.29
- 52 Week High
- RDZN $7.17
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- RDZN 55.26
- RFL 45.87
- Support Level
- RDZN $1.18
- RFL $1.74
- Resistance Level
- RDZN $2.87
- RFL $1.92
- Average True Range (ATR)
- RDZN 0.43
- RFL 0.09
- MACD
- RDZN -0.01
- RFL -0.00
- Stochastic Oscillator
- RDZN 34.84
- RFL 40.91
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.